Nipah Virus Inhibitor Knowledgebase (NVIK): a combined evidence approach to prioritise small molecule inhibitors

Revision as of 02:17, 7 February 2026 by Nhmkerala (talk | contribs) (Created paper page - 2026-02-07T07:47:25.865834)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Authors: Bhupender Singh, Nishi Kumari, Ayush Upadhyay, Bhavini Pahuja, Eugenia Covernton, Kishan Kalia, Kanika Tuteja, Priyanka Rani Paul, Rakesh Kumar, Mayur Sudhakar Zarkar, Anshu Bhardwaj

Year: 2025

Journal: Journal of Cheminformatics

DOI: 10.1186/s13321-025-01049-6

Summary

This paper presents the Nipah Virus Inhibitor Knowledgebase (NVIK), a resource for NiV drug discovery containing manually curated NVIs with IC50/EC50 values in the nanomolar range. The authors prioritised top 10 NVIs based on robustness of assays, physicochemical properties and their toxicity profiles.

Key Findings

  • Creation of NVIK containing 220 NVIs with 142 unique small molecule inhibitors
  • Reported IC50/EC50 values as low as 0.47 nM for some inhibitors
  • 124 (87.32%) compounds cleared the PAINS filter
  • More than 90% of the NVIs are singletons with diverse structural features
  • Top 10 NVIs prioritised based on robustness, physicochemical properties and toxicity profiles

Methodology

  • Study Type: Research

Topics

Cheminformatics, Antivirals, Nipah Virus

Relevance

The NVIK can contribute to the development of druglike anti-nipah molecules and address the urgent need for accelerated research & development for NiV.

Source

View the entire paper: File:S13321-025-01049-6.pdf